Form 4: Sabra Health Care REIT Director, Clifton J. Porter II, Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Clifton J. Porter II reports acquisition and disposal of Sabra Health Care REIT stock units due to dividend equivalent payments.

Summary

  • On May 31, 2024, Clifton J. Porter II, a director of Sabra Health Care REIT, Inc. (SBRA), reported transactions involving the company's common stock.
  • Porter acquired 733 shares of common stock due to dividend equivalent payments related to previously granted stock units under the company's 2009 Performance Incentive Plan.
  • The price of the acquired stock was $0.
  • Following the reported transaction, Porter beneficially owns 36,835 shares of common stock, which includes 1,035 unvested stock units and 35,276 vested stock units with deferred payment.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Positives

  • The acquisition of shares through dividend equivalent payments indicates the director's continued stake in the company's performance.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
05/31/2024Date of transaction: Acquisition of stock units due to dividend equivalent payments.
06/04/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.